CEP55 contributes to human gastric carcinoma by regulating cell proliferation
Authors:
- 4 January 2014
- journal article
- research article
- Published by Springer Nature in Tumor Biology
- Vol. 35 (5) , 4389-4399
Abstract
Centrosomal protein 55 (CEP55) is the latest found member in the centrosomal relative protein family, which participates in cell-cycle regulation. CEP55 exists in many kinds of normal tissues and tumour cells such as hepatocellular carcinoma, and is important in carcinogenesis. However, the role of CEP55 in the pathogenesis of gastric cancer (GC) remains unclear. The mRNA levels of CEP55 in GC tissues and GC cell lines were examined by quantitative real-time PCR, and the protein expression of CEP55 in GC tissues was detected by Western blot and immunohistochemistry. The role of CEP55 in regulating the proliferation of GC cell lines was investigated both in vitro and in vivo. CEP55 was strongly upregulated in human GC, indicating that CEP55 contributed to carcinogenesis and progression of GC. Ectopic overexpression of CEP55 enhanced the cell proliferation, colony formation, and tumourigenicity of GC cells, whereas CEP55 knockdown inhibited these effects. We discovered that cell transformation induced by CEP55 was mediated by the AKT signalling pathway. Overexpression of CEP55 enhanced the phosphorylation of AKT and inhibited the activity of p21 WAF1/Cip1. In addition, cellular proliferation was suppressed as a result of cell cycle arrest at the G2/M phase in CEP55-knockdown cells. CEP55 expression was elevated in GC compared with normal control tissues. Credible evidence showed that CEP55 can be a potential therapeutic target in GC.Keywords
This publication has 39 references indexed in Scilit:
- Phosphatidylinositol 3'-kinase, mTOR, and Glycogen synthase kinase-3β mediated regulation of p21 in human urothelial carcinoma cellsBMC Urology, 2011
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- Status of PI3K inhibition and biomarker development in cancer therapeuticsAnnals of Oncology, 2009
- p21 in cancer: intricate networks and multiple activitiesNature Reviews Cancer, 2009
- VEGFA Upregulates FLJ10540 and Modulates Migration and Invasion of Lung Cancer via PI3K/AKT PathwayPLOS ONE, 2009
- Esophagectomy for T1 Esophageal Cancer: Outcomes in 100 Patients and Implications for Endoscopic TherapyThe Annals of Thoracic Surgery, 2009
- Cep55, a Microtubule-bundling Protein, Associates with Centralspindlin to Control the Midbody Integrity and Cell Abscission during CytokinesisMolecular Biology of the Cell, 2006
- Perturbations of the AKT signaling pathway in human cancerOncogene, 2005
- The Hallmarks of CancerCell, 2000
- Cancer Cell CyclesScience, 1996